ArticleCell reports. Medicine2025

Targeting TET3 suppresses group 3 medulloblastoma stemness and progression via impairing hypomethylation of Otx2 super-enhancer.

Xuan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.